cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Black Diamond Therapeutics
14 own
14 watching
Current Price
$3
$0.09
(3.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
109.1M
52-Week High
52-Week High
4.21
52-Week Low
52-Week Low
1.18
Average Volume
Average Volume
0.08M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization109.1M
icon52-Week High4.21
icon52-Week Low1.18
iconAverage Volume0.08M
iconDividend Yield--
iconP/E Ratio--
What does the Black Diamond Therapeutics do?
Black Diamond Therapeutics, Inc. is a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies. Black Diamond Therapeutics goal is to bring precision oncology medicine to a greater number of patients. Black Diamond Therapeutics targets undrugged mutations in patients with genetically-defined cancers. The foundation of Black Diamond Therapeutics is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. Black Diamond Therapeutics principal executive office is located at 139 Main Street, Cambridge, MA 02142
Read More
How much money does Black Diamond Therapeutics make?
News & Events about Black Diamond Therapeutics.
Globe Newswire
1month ago
CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing MasterKey therapies designed to overcome limitations of existing therapies by targeting families of oncogenic driver ...
Globe Newswire
1month ago
CAMBRIDGE, Mass. and NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that Chairman of the Board of Directors, Robert (Bob) A. Ingram, ...
Globe Newswire
1month ago
- $30M Series A investment from Versant Ventures and NEA- CAMBRIDGE, Mass. and NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced the ...
Globe Newswire
2 months ago
CAMBRIDGE, Mass. and NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of Master Key therapies, today announced that company management will participate in three upcoming ...
Frequently Asked Questions
Frequently Asked Questions
What is Black Diamond Therapeutics share price today?
plus_minus_icon
Can Indians buy Black Diamond Therapeutics shares?
plus_minus_icon
How can I buy Black Diamond Therapeutics shares from India?
plus_minus_icon
Can Fractional shares of Black Diamond Therapeutics be purchased?
plus_minus_icon
What are the documents required to start investing in Black Diamond Therapeutics stocks?
plus_minus_icon
What is today’s traded volume of Black Diamond Therapeutics?
plus_minus_icon
What is today’s market capitalisation of Black Diamond Therapeutics?
plus_minus_icon
What is the 52-Week High and Low Range of Black Diamond Therapeutics?
plus_minus_icon
What percentage is Black Diamond Therapeutics down from its 52-Week High?
plus_minus_icon
What percentage is Black Diamond Therapeutics up from its 52-Week Low?
plus_minus_icon
Current Price
$3
$0.09
(3.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00